Catalyst Wire Dossier Catalyst Wire Dossier

VAX-ID Hepatitis B vaccine

hepatitis B vaccine delivered dermally via VAX-ID · Novosanis NV
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VAX-ID Hepatitis B vaccine, covering 2017-03-28 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID [Phase 1]

See pricing